EVERSANA
Marty Culjat serves as the SVP, Global Head of Digital Medicine & Regulatory Innovation at EVERSANA and previously held the position of SVP Scientific & Regulatory Affairs at both Mymee and Dthera Sciences. Additionally, Marty worked as VP of Product Development at CureMatch Inc and co-founded Mothership Medical, where the role of VP Product Development was also undertaken. Marty holds a PhD in Biomedical Engineering obtained from UCLA between 2002 and 2005 and a MS in Biomedical Engineering from UCLA earned from 2000 to 2002.
This person is not in any teams
This person is not in any offices
EVERSANA
7 followers
EVERSANA™ is the leading provider of global services to the life sciences industry. The company’s integrated solutions are rooted in the patient experience and span all stages of the product life cycle to deliver long-term, sustainable value for patients, prescribers, channel partners and payers. The company serves more than 500 organizations, including innovative start-ups and established pharmaceutical companies, to advance life sciences solutions for a healthier world. To learn more about EVERSANA, visit eversana.com.